Ultra-high throughput and advanced testing methods

During the IFCC and EuroMedLab congress in Berlin, Beckmann Coulter launched into Europe its AU 5800, which, the firm reports, improves processing time compared to current systems and therefore meets the demands of ever faster workflow in clinical laboratories.

Photo: Ultra-high throughput and advanced testing methods
Photo: Ultra-high throughput and advanced testing methods

‘In figures, the system performs up to 2,000 photometric chemistry tests per hour for a single modus. With a four-unit configuration, labs can achieve up to 8,000 tests per hour and can gain even more efficiency by adding a dual ISE flow cell that increases maximum throughput of nearly 10,000 tests per hour.’ The system can be used as a stand-alone instrument or is designed for connectivity with the company’s automation solution, further allowing for potential integration with clinical information systems and immunoassay testing platforms.

Increased clinical accuracy in PSA testing

Another highlight was the presentation of the Prostate Health Index (phi) featured in European Hospital 2/2011. This new test is reported to improve PSA measurement by combining three automated blood tests (p2PSA, total PSA and free PSA) in one index for improved specificity in estimating prostate cancer probability prior to biopsy. When phi is installed, the analyser automatically calculates and reports the results, supporting a decision to recommend a prostate biopsy. Presented during this year’s European Congress of Urology, the first results of the clinical impact of the new tests indicate that phi significantly improves the accuracy of total and free PSA in predicting the presence of prostate cancer and in correlating cancer aggressiveness.

20.06.2011

Read all latest stories

Related articles

Photo

Blood poisoning

Exploring the importance and challenges of early sepsis diagnosis

On the occasion of this year's World Sepsis Day, we spoke with Elena Sukhacheva, Ph.D., director of medical and scientific affairs at Beckman Coulter, about the status quo and outlook on sepsis…

Photo

Hematology

Early sepsis indicator helps identifying patients at risk

The critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early…

Photo

Innovation

Hematology: Advancements and future trends

While the role of the laboratory in disease diagnosis and management has expanded in recent years, causing an overwhelming rise in testing demands, the availability of skilled technologists and…

Related products

Beckman Coulter – Access 25(OH) Vitamin D Total

Immunoassays

Beckman Coulter – Access 25(OH) Vitamin D Total

Beckman Coulter, Inc.
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter, Inc.
Beckman Coulter – Access Active B12

Immunoassays

Beckman Coulter – Access Active B12

Beckman Coulter, Inc.
Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter, Inc.
Beckman Coulter – Anti-Mullerian Hormone (AMH)

Immunochemistry

Beckman Coulter – Anti-Mullerian Hormone (AMH)

Beckman Coulter, Inc.